CDKN2A and CDH1-related diffuse gastric and lobular breast cancer syndrome: As shown in Table 1, the overall test positivity of p16/Ki-67 dual staining (33.1%) was a little lower than that of the HR-HPV (35.9%) and LBC (36.3%) in the whole population (p < 0.05).